SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-029336
Filing Date
2022-08-12
Accepted
2022-08-12 17:00:32
Documents
7
Period of Report
2022-08-12

Document Format Files

Seq Description Document Type Size
1 6-K sndl-6k_20220809.htm 6-K 17293
2 EX-99.1 sndl-ex991_7.htm EX-99.1 3110380
3 EX-99.2 sndl-ex992_9.htm EX-99.2 1931444
4 52-109F2 CEO CERT sndl-ex993_8.htm EX-99.3 25942
5 52-109F2 CFO CERT sndl-ex994_6.htm EX-99.4 25688
6 GRAPHIC g1tfq5i3hcy5000001.jpg GRAPHIC 4474
7 GRAPHIC gury1ewyqb1l000001.jpg GRAPHIC 4474
  Complete submission text file 0001564590-22-029336.txt   5124493
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 221161025
SIC: 2833 Medicinal Chemicals & Botanical Products